Vantage Data Centers to Continue Deploying Renewable Generator Fuel, Plans Rollout in Additional Markets in 2023
13.9.2023 15:02:00 EEST | Business Wire | Press release
Vantage Data Centers, a leading global provider of hyperscale data center campuses, today announced the continued deployment of hydrotreated vegetable oil (HVO), a renewable fuel to replace conventional diesel fuel in generators. The company will roll out HVO in several of its largest markets in North America and EMEA.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230913529341/en/
Vantage Data Centers continues rollout of HVO in several of its largest markets, including its Cardiff campus pictured here. (Photo: Business Wire)
HVO is 100% biodegradable and non-toxic, offering a more sustainable fuel option while delivering the same level of functionality as traditional diesel. Repurposing waste oils like vegetable oil to create sustainable fuels significantly reduces the embodied carbon due to the cleaner sourcing and creation process. Leveraging HVO offers an actionable opportunity for Vantage and other data center operators to take a positive step toward reducing carbon emissions.
Initially deployed as a pilot at Vantage’s Cardiff, Wales campus in 2022, the company’s deployment of HVO as an alternative to diesel fuel yielded progress toward its carbon goals without the need for new or updated infrastructure. Given the success of the pilot, Vantage officially implemented HVO at its newest facility, CWL13, on the Cardiff campus and is currently working to deploy the renewable fuel throughout the rest of the campus. In addition, Vantage will deploy HVO in one of its North American flagship markets, Santa Clara, California, by the end of the year. Vantage is planning deployments in additional markets subject to fuel availability.
“Making the switch to renewable diesel is one of the many ways we are reducing the carbon emissions of our operations. Reaching net zero by 2030 is an incredibly ambitious goal that will require us to implement a wide variety of solutions. Our focus is on maintaining reliability and affordability while achieving emissions reductions,” said Amanda Abell, senior director of sustainability at Vantage. “We look forward to continuing the rollout of HVO at our campuses across North America and EMEA, where available, in addition to the other programs we have in place to reach our sustainability targets.”
The broad launch of hydrotreated vegetable oil comes as the company progresses toward its sustainability goals. The use of renewable diesel fuels significantly reduces the embodied carbon of the fuel consumed in diesel generators, which helps to reduce Scope 3 emissions associated with the company’s supply chain. According to fuel suppliers, the use of HVO reduces the lifecycle carbon emissions by 65-90% compared to conventional diesel.
In 2022, Vantage partnered with the Data Center Coalition (DCC) and its members to lead a technical working group focused on driving market support for HVO as availability and costs vary by geography. Based in the Northern Virginia area, where HVO prices are approximately 95 percent higher than diesel fuel, DCC seeks to influence the supply chain and stakeholders to unlock increased availability.
“Vantage is working with industry through the Data Center Coalition to accelerate the viability and use of renewable diesel fuels,” said Mark Freeman, vice president, global marketing and public policy at Vantage and Data Center Coalition board member. “By collaborating and sharing information with peers, it helps the entire sector move faster. It is our hope that through partnerships we can convince policy makers, stakeholders and supply chains of the HVO benefits and enlist their help in achieving the widespread production and distribution of the renewable fuel in markets that lack reliable, cost-effective and timely access today.”
“There is strong industry interest in transitioning from diesel as quickly as is practical. While there are no ‘silver bullet’ technological solutions available today to replace backup diesel generators at scale, data centers are actively seeking and evaluating alternatives that can provide environmental sustainability benefits and similar reliability, fuel availability, siting flexibility and workplace safety protections,” explained Josh Levi, president of the Data Center Coalition. “We are seeing widespread interest in leveraging hydrotreated vegetable oil as an alternative to conventional diesel. In fact, a recent member survey found that 92 percent of respondents are interested in piloting renewable diesel in the Northern Virginia market within the next one to two years. We’re pleased to see support for this sustainable fuel and will continue to work closely with member companies as we advocate to speed the viability and availability of alternative, reliable sources for backup energy.”
In addition to Vantage’s continued rollout of HVO, the company is also implementing generator run-time reduction measures to eliminate the creation of emissions from the start. By using an optimized staged implementation of testing and maintenance procedures, Vantage anticipates achieving a 25 to 75 percent reduction in fuel consumption and associated emissions. Vantage is also installing active emissions control systems known as Selective Catalytic Reductions (SCRs) on generators in select markets. SCRs reduce nitrogen oxide emitted from the company’s diesel generators by up to 90%. SCRs are already installed at many facilities across Vantage’s Warsaw, Berlin, Frankfurt and California campuses with additional installations planned for the future.
For more information about Vantage’s sustainability program and priorities, download the 2022 ESG report here.
About Vantage Data Centers
Vantage Data Centers powers, cools, protects and connects the technology of the world’s well-known hyperscalers, cloud providers and large enterprises. Developing and operating across five continents in North America, EMEA and Asia Pacific, Vantage has evolved data center design in innovative ways to deliver dramatic gains in reliability, efficiency and sustainability in flexible environments that can scale as quickly as the market demands.
For more information, visit http://www.vantage-dc.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230913529341/en/
Contact information
Press Contacts
Mark Freeman
Vantage Data Centers
mfreeman@vantage-dc.com
+1-202-680-4243
Robin Bectel
REQ for Vantage Data Centers
vdc@req.co
+1-202-936-6335
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 21:00:00 EET | Press release
Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham, MSc, MD, FRCPC, dermatologist, SKiN Centre for Dermatology, Peterborough, Ontario, Canada, principal investigator for the Latitude PsO studies and presenting author. “These efficacy and safety results show it’s possible for a once-daily pill to deliver rapid, lasting skin clearance, highlighting the potential of zasoc
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 21:00:00 EET | Press release
Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3 STOP-HS clinical trial program in adult patients (≥18 years) with moderate to severe hidradenitis suppurativa (HS). The late-breaking oral presentation of these data is taking place at the 2026 American Academy of Dermatology (AAD) Annual Meeting, being held March 27-31, 2026, in Denver (Session: S034 – Late-Breaking Research: Session 2. Saturday, March 28, 2026, 1:00-4:00 p.m. MT). “The 54-week results from the STOP-HS program deliver compelling, long-term evidence supporting the potential of povorcitinib for patients with moderate to severe HS,” said Pablo J. Cagnoni, M.D., President and Global Head of Research and Development, Incyte. “Across both studies, povorcitinib demonstrated substantial and durable improvements over time in key measures of treatment success and meaningful clinical ben
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 17:00:00 EET | Press release
Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-breaking session at the 2026 American Academy of Dermatology (AAD) Annual Meeting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260328320362/en/ Atopic dermatitis is the most common inflammatory skin disorder in children, yet treatment options in the moderate-to-severe pediatric setting are limited.5 The disease can have a significant impact on quality of life for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school and relationships.5-8 “Atopic dermatitis can affect many aspects of children’s lives including schoolwork, emotional development
Angelalign Technology (6699.HK) Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 21:56:00 EET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 19:46:00 EET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
